The correct way to restore milk with cabergoline, scientific weaning is effortless
Cabergoline is a drug commonly used to treat hyperprolactinemia (HPRL), especially in mothers who have breast problems caused by high prolactin or who need to stop breastfeeding for other reasons. Cabergoline can help suppress lactation. Breastfeeding usually refers to the cessation or decrease in breast milk production. When using cabergoline to restore milk, correct usage is critical.
First of all, the dosage of cabergoline is usually determined by the doctor based on the patient's specific condition. Typically, the recommended dose of cabergoline is 0.25 mg orally twice weekly when starting treatment and gradually increasing to 0.5 mg twice weekly. The specific dosage and frequency of medication should be adjusted according to your doctor's recommendations. When taking cabergoline, a reduction in milk production is usually seen within the first day of use, but full milk return may take several days to a week. During treatment, patients may experience mild dizziness, nausea, and other side effects, which are often common reactions to medications.

In addition to medical treatment, patients should also pay attention to avoid over-stimulating the breasts during the breastfeeding process, such as avoiding excessive massage or using a breast pump. Proper breast care, including wearing a comfortable bra, can also help reduce discomfort and facilitate the milk return process. During medication, unnecessary breast stimulation should be avoided to avoid affecting the effect of the medication.
The most important thing is that patients should strictly follow the doctor's instructions when using cabergoline and have regular follow-up visits to ensure the safety and effectiveness of the medication. In some cases, cabergoline may not be suitable for all patients, especially those with drug allergies, so medical history and possible drug reactions should be discussed in detail with your doctor before starting treatment.
Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)